Stem Cell therapy has been investigated across many theraputic specialties. As a potential treatment option, current studies are investigating their potential for restoring blood supply for ischemic myocardium in refractory angina patients.
Adult stem cells have the ability to self renew and differentiate into other cell types, before they differentiate into more specialized progeny, known as progenitor cells. Progenitor cells can be characterized by the cells surface markers they expresse. Progenitor cells that express CD34+ markers, specifically, have been shown in previous clinical studies to support cardiac proliferation and repair.
If you are experiencing problems viewing the videos, please click here to be redirected to my Vimeo page.